ArticleOrthopaedic journal of sports medicine2026
Comparison of Bone Marrow Stimulation and Particulated Autologous Cartilage Transplantation for Osteochondral Lesions of the Talus With a 2-Year Follow-up.
Article in Orthopaedic journal of sports medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Intraosseous Bone Marrow Concentrate and Long-Term Procedure-Free Survival in Bilateral Non-Traumatic Ankle Osteoarthritis: A Contralateral-Controlled Study.Medicina (Kaunas, Lithuania) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Osteochondral lesions of the talus (OLTs) are a common cause of disability and chronic ankle pain. Many surgical treatment methods are currently used to treat OLTs, including particulated autologous cartilage transplantation (PACT). Nonetheless, the relative outcomes of PACT for OLTs are unclear. Purpose: To compare the short-term efficacy of bone marrow stimulation (BMS) and PACT in patients with OLTs. Study Design: Cohort study; Level of evidence, 3. Methods: Consecutive symptomatic patients with OLT who underwent BMS or PACT from March 2015 to December 2022 were retrospectively evaluated for at least 2 years. Preoperative radiography and magnetic resonance imaging (MRI) were performed in all patients. Follow-up second-look arthroscopy and MRI were performed approximately 1 year postoperatively. Clinical outcomes were assessed using the pain visual analog scale (VAS), American Orthopaedic Foot & Ankle Society (AOFAS) score, and Foot and Ankle Outcome Score (FAOS). The quality of regenerated cartilage was evaluated using Magnetic Resonance Observation of Cartilage Repair Tissue (MOCART) scores and International Cartilage Repair Society (ICRS) grades and scores. Continuous variables were compared using independent Results: A total of 48 and 16 patients (48 and 16 ankles) were enrolled in the BMS and PACT groups, respectively. No significant differences existed in demographic characteristics between the groups. Preoperatively, some clinical parameters were significantly worse in the PACT group (VAS 5.2 ± 2.3 vs 6.4 ± 0.8, Conclusion: Our study demonstrated that PACT achieved significantly superior morphologic cartilage regeneration compared with BMS in OLTs at 1-year follow-up. However, the differences in clinical outcomes between the 2 treatments were not significant. Notwithstanding, additional follow-up studies are needed to assess the effects of PACT on long-term outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.